卷 12, 编号 3 (2010)
- 年: 2010
- 文章: 23
- URL: https://journals.rcsi.science/1815-1434/issue/view/1478
Articles
Na territorii Rossiyskoy FederatsiiGertseptin zaregistrirovan v kachestve terapiirasprostranennoy adenokartsinomy zheludkaili pishchevodno-zheludochnogo perekhodas opukholevoy giperekspressiey HER2
Journal of Modern Oncology. 2010;12(3):4-5
4-5
Obzor konferentsii ekspertovv oblasti lekarstvennoy terapii rakapochki «Novye vozmozhnosti v terapiimetastaticheskogo raka pochki»
Journal of Modern Oncology. 2010;12(3):6-7
6-7
Gastrointestinal'nye stromal'nyeopukholi: obzor materialov ASCO 2010
Journal of Modern Oncology. 2010;12(3):7-11
7-11
Dobavlenie Zomety (zoledronata)k ad\"yuvantnoy endokrinoterapiiuvelichivaet vyzhivaemost' bol'nykhrannim retseptor-pozitivnym rakommolochnoy zhelezy
Journal of Modern Oncology. 2010;12(3):12-15
12-15
Spornye aspekty HER2-diagnostiki
Journal of Modern Oncology. 2010;12(3):15-19
15-19
Bevatsizumab v lechenii HER2-negativnogometastaticheskogo raka molochnoy zhelezy:sovremennye dannye ob effektivnostii bezopasnosti
Journal of Modern Oncology. 2010;12(3):19-23
19-23
Kapetsitabin v ad\"yuvantnoy terapiiraka molochnoy zhelezy
Journal of Modern Oncology. 2010;12(3):23-27
23-27
Vozmozhnosti khimioterapii rakamolochnoy zhelezy, rezistentnogok antratsiklinam i taksanam
Journal of Modern Oncology. 2010;12(3):28-33
28-33
Rol' lapatiniba v terapiimetastaticheskogo raka molochnoyzhelezy s ekspressiey gormonal'nykhretseptorov
Journal of Modern Oncology. 2010;12(3):34-38
34-38
Izuchenie gemtsitabina (Gemzar®)i tsisplatina v pervoy linii terapiirasprostranennogo raka yaichnika(issledovanie II fazy)
Journal of Modern Oncology. 2010;12(3):40-45
40-45
Ingibitory tirozinkinazy retseptoraepidermal'nogo faktora rosta:pokhozhie, no raznye? (Referat)
Journal of Modern Oncology. 2010;12(3):46-52
46-52
Opyt primeneniya Avastina (bevatsizumaba)v sochetanii s khimioterapiey v lecheniirasprostranennykh form nemelkokletochnogoraka legkogo v otdelenii torakal'noyonkologii
Journal of Modern Oncology. 2010;12(3):53-57
53-57
Vozmozhnosti targetnoy terapiipri lechenii neyroendokrinnykhopukholey zheludochno-kishechnogotrakta i podzheludochnoy zhelezy
Journal of Modern Oncology. 2010;12(3):57-61
57-61
Primenenie preparata sorafenibpri lechenii gepatotsellyulyarnoy kartsinomy(Obzor klinicheskikh i neinterventsionnykhissledovaniy: issledovanie GIDEON)
Journal of Modern Oncology. 2010;12(3):62-64
62-64
Panitumumab v terapii metastaticheskogokolorektal'nogo raka: dannye klinicheskikhissledovaniy, problema kozhnoy toksichnosti
Journal of Modern Oncology. 2010;12(3):65-70
65-70
Trabektedin v lekarstvennom lecheniisarkom myagkikh tkaney
Journal of Modern Oncology. 2010;12(3):71-74
71-74
Mesto konservativnoy terapiiv lechenii raka slizistoy obolochki shcheki
Journal of Modern Oncology. 2010;12(3):76-79
76-79
Nekhodzhkinskie limfomy kishechnika -pervichnoe ekstranodal'noe porazhenie
Journal of Modern Oncology. 2010;12(3):80-84
80-84
Mekhanizmy mobilizatsii gemopoeticheskikhpredshestvennikov granulotsitarnymkoloniestimuliruyushchim faktorom
Journal of Modern Oncology. 2010;12(3):84-88
84-88
Anemiya i sposoby ee korrektsiiu onkologicheskikh bol'nykh
Journal of Modern Oncology. 2010;12(3):89-93
89-93
Bezopasnost' ibandronovoy kislotypri dlitel'nom primenenii
Journal of Modern Oncology. 2010;12(3):93-94
93-94
Astenicheskie rasstroystva,assotsiirovannye s khimioterapieyzlokachestvennykh novoobrazovaniy(Obzor literatury)
Journal of Modern Oncology. 2010;12(3):96-101
96-101
Tekhnicheskie vozmozhnosti primeneniyakleevoy substantsii pri khirurgicheskikhvmeshatel'stvakh na organakh bryushnoypolosti
Journal of Modern Oncology. 2010;12(3):102-112
102-112